Loading
Clorox Co Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 24 Nov 2025.
Clorox Co: what insiders have been doing
Every trade that managers of Clorox Co disclose to SEC (Form 4) is tracked on this page. The company sits in the Food & Agriculture sector and is based in Clorox Building, United States. It was founded in 1913. Between 18 October 2025 and 18 October 2026, 10 insiders published 43 filings.
Every open-market trade in the period is a purchase: 1 purchase worth €361k, from 1 insider, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. At €361k, the purchase published on 24 November 2025 by Breber Pierre R is the largest of the period. Those buying include 1 senior executive.
The clock since the last published purchase (24 November 2025) now reads 328 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade.
For context, the typical company on the same exchange (median of 5,808 companies) published 19 filings over the same period, against 43 filings here. The full history, which starts in 2016, counts 2 purchases against 7 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 30 June 2025), the company reported revenue of 7.10 bn USD and net income of 810.0 m USD, with a dividend of 4.88 USD per share.
For comparison within the same sector, see the insider buying recorded at Village Farms International, Inc. and Orkla ASA. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
298
Thresholds
n/a
Buy Volume
€844,276
2 ops. · all time
Sell Volume
€1M
7 ops. · all time
Who traded when
BuySalePierre R. Breber2 buys
Kirsten Marriner1 sale
Since the insiders bought
- +18.6%Entry US$106.87 · Close at T+90 US$126.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Clorox Co Hold (neutral), based on 17 analysts. Average price target: US$99.29.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,400 of 24,148 companies
59.1
score / 100
Value56
Quality62
FCF yld3.8%
Earn yld5.6%
EV/EBITDA13.7x
ROE164%
Gross mgn42%
Net mgn8.7%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
US$84.45
Analyst consensus
17 analystsHold
US$74.00Target US$99.29(+18%)US$154.00
Income statement
RevenueUS$6.7B
Gross profitUS$2.8B42% margin
EBITDAUS$1.2B17% margin
Net incomeUS$587M8.7% margin
Valuation
PER (trailing)17.6x
PER (forward)13.6x
P/Book113.5x
Beta0.57
Balance sheet & cash
Market capUS$10.2B
Total debtUS$5.5B
Free Cash FlowUS$405M
Debt / Equity2221%
Profitability & ownership
ROE163.8%
ROA8.3%
% insiders0.7%
% institutions88.4%
Last declaration on 7 October 2026
Declarations298 total
29,352 shares@ US$80.410.024% mcap5.7% of flowCommon StockSEC:0001225208-26-008314:0
692 shares@ US$80.410.0006% mcap0.1% of flowCommon StockSEC:0001225208-26-008314:1
11,989 shares@ US$80.410.0097% mcap2.3% of flowCommon StockSEC:0001225208-26-008314:2
1,172 shares@ US$80.410.0010% mcap6.4% of flowCommon StockSEC:0001225208-26-008313:0
30 shares@ US$80.410.0000% mcap0.2% of flowCommon StockSEC:0001225208-26-008313:1
339 shares@ US$80.410.0003% mcap1.9% of flowCommon StockSEC:0001225208-26-008313:2
6,637 shares@ US$80.410.0054% mcap5.4% of flowCommon StockSEC:0001225208-26-008312:0
1,951 shares@ US$80.410.0016% mcap1.6% of flowCommon StockSEC:0001225208-26-008312:1
2,142 shares@ US$80.410.0017% mcap1.7% of flowCommon StockSEC:0001225208-26-008312:2
4,191 shares@ US$80.410.0034% mcap5.5% of flowCommon StockSEC:0001225208-26-008311:0
100 shares@ US$80.410.0001% mcap0.1% of flowCommon StockSEC:0001225208-26-008311:1
1,532 shares@ US$80.410.0012% mcap2.0% of flowCommon StockSEC:0001225208-26-008311:2
6,637 shares@ US$80.410.0054% mcap5.8% of flowCommon StockSEC:0001225208-26-008310:0
2,296 shares@ US$80.410.0019% mcap2.0% of flowCommon StockSEC:0001225208-26-008310:1
2,351 shares@ US$80.410.0019% mcap2.1% of flowCommon StockSEC:0001225208-26-008310:2
1,677 shares@ US$80.410.0014% mcap4.5% of flowCommon StockSEC:0001225208-26-008309:0
580 shares@ US$80.410.0005% mcap1.5% of flowCommon StockSEC:0001225208-26-008309:1
1,031 shares@ US$80.410.0008% mcap2.8% of flowCommon StockSEC:0001225208-26-008309:2
1,106 shares@ US$80.410.0009% mcap1.6% of flowCommon StockSEC:0001225208-26-008308:0
11,436 shares@ US$83.940.0094% mcap11.4% of flowCommon StockSEC:0001225208-26-007947:0
50,988 shares@ US$83.940.042% mcap11.0% of flowCommon StockSEC:0001225208-26-007949:0
10,721 shares@ US$83.940.0088% mcap16.2% of flowCommon StockSEC:0001225208-26-007948:0
11,913 shares@ US$83.940.0098% mcap35.7% of flowCommon StockSEC:0001225208-26-007950:0
13,342 shares@ US$83.940.011% mcap19.5% of flowCommon StockSEC:0001225208-26-007951:0
12,389 shares@ US$83.940.010% mcap11.2% of flowCommon StockSEC:0001225208-26-007952:0
25 of 298 declarations
About Clorox Co
The Clorox Company (NYSE: CLX) is a leading U.S. consumer products group with a strong position in household care, disinfecting, hygiene, and selected food-related categories. Founded in 1913 as The Electro-Alkaline Company, Clorox started with liquid bleach production in Oakland, California, where the company is still headquartered today. Over more than a century, it has evolved from a single-product bleach business into a diversified branded platform sold in more than 100 markets, with operations in approximately 25 countries or territories. For French-speaking investors in Europe, Clorox is best viewed as a defensive U.S. listed consumer staples company, traded on the NYSE in the United States, with revenues supported by essential everyday products and strong brand loyalty.
Clorox’s portfolio spans several core business lines. Its health and wellness activities include cleaning and disinfecting products, laundry additives, and professional offerings. Its lifestyle segment covers dressings, dips, seasonings, sauces, water-filtration products, and natural personal care. Well-known brands include Clorox, Pine-Sol, Tilex, Liquid-Plumr, Glad, Fresh Step, Kingsford, Hidden Valley, Brita, and Burt’s Bees. The company also serves professional customers through CloroxPro and Clorox Healthcare. This broad portfolio gives Clorox exposure to both at-home consumption and institutional use cases, while reducing reliance on any single brand or subcategory.
Read moreShow less
From a competitive standpoint, Clorox competes against large national brands as well as private-label products. Its edge comes from brand equity, distribution reach, category expertise, and ongoing product innovation. The company says about 80% of sales come from brands that hold a No. 1 or No. 2 market share position in their categories, which is an important indicator of franchise strength. Clorox primarily focuses on midsized categories that it considers financially attractive, rather than chasing broad commodity exposure. That strategy supports pricing power and margin resilience, although execution remains sensitive to supply chain conditions, input costs, retailer inventory patterns, and marketing effectiveness.
Recent developments are important for investors. In April 2026, Clorox completed the acquisition of GOJO Industries, maker of Purell, expanding its portfolio into hand hygiene and health solutions. Management described the deal as complementary to Clorox’s consumer brand-building capabilities and its B2B strengths. In its latest quarterly updates for fiscal 2026, the company noted that results were influenced by ERP-related inventory dynamics in the United States, while also pointing to the contribution expected from GOJO. Clorox therefore remains a mature but evolving consumer staples name: a household-product leader with international reach, a long operating history, a strong U.S. NYSE listing, and a portfolio that is being adjusted to capture additional health and hygiene demand.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
